SCHEMBL8423633

SCHEMBL8423633

CNCC(C)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16297563 1.00
SCHEMBL22598291 1.00
SCHEMBL6239009 0.79
SCHEMBL9192134 0.78 GABBR2 (0.42)
SCHEMBL22898343 0.77
SCHEMBL10899129 0.77
SCHEMBL18902509 0.75
SCHEMBL9323831 0.75 GABBR2 (0.40)
SCHEMBL9323883 0.75 GABBR2 (0.40)
SCHEMBL6274547 0.73 KISS1R (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116211887-A Composition for treating acid-base imbalance 特里赛达公司 2023-06-06 CN claimed
US-11434433-B2 Composition for removal of sulfur-containing compound KURARAY CO., LTD. (JP) 2022-09-06 US claimed
US-20190209607-A1 COMPOSITIONS FOR TREATING ACID-BASE DISORDERS TRICIDA, INC. 2019-07-11 US claimed
EP-3287133-B1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION TRICIDA INC (US) 2019-04-17 EP claimed
EP-3452057-A1 COMPOSITIONS FOR TREATING ACID-BASE DISORDERS Tricida Inc. (US) 2019-03-13 EP claimed
WO-2017193050-A1 COMPOSITIONS FOR TREATING ACID-BASE DISORDERS TRICIDA, INC. (US) 2017-11-09 WO claimed
EP-3003327-A1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION Tricida Inc. (US) 2016-04-13 EP claimed
WO-2014197725-A1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION TRICIDA, INC. (US) 2014-12-11 WO claimed
US-5874105-A DISPERSING LONG CHAIN ACYL N,N-DIMETHYL-1,N-DIAMINO ALKYL MOLECULES IN A BUFFERING SOLUTION WITH A LOAD MATERIAL FOR DELIVERY, TO FORM A DISPERSION, SUBJECTING DISPERSION TO HIGH SHEAR; DRUG DELIVERY COLLABORATIVE LABORATORIES, INC. (US) 1999-02-23 US claimed
EP-3812761-B1 PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION RENOSIS INC (US) 2025-12-24 EP disclosed
US-20250222021-A1 METHOD OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-07-10 US disclosed
US-20250025494-A1 COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-01-23 US disclosed
US-20250009785-A1 HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS RENIBUS THERAPEUTICS, INC. 2025-01-09 US disclosed
CN-118662644-A Composite and use thereof 学校法人顺天堂 2024-09-20 CN disclosed
US-5443829-A For enhancing delivery of drugs across mucous membranes of animals CAMBRIDGE BIOTECH CORPORATION (US) 1995-08-22 US disclosed
EP-0658111-A1 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS CAMBRIDGE BIOTECH CORPORATION (US) 1995-06-21 EP disclosed
WO-1994001118-A1 METHODS FOR ENHANCING DRUG DELIVERY WITH MODIFIED SAPONINS CAMBRIDGE BIOTECH CORPORATION (US) 1994-01-20 WO disclosed
US-5273965-A A reduced and hydrolyzed saponin from a Quillaja saponaria extract CAMBRIDGE BIOTECH CORPORATION (US) 1993-12-28 US disclosed
US-4189306-A OCTANE RATING IMPROVERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-02-19 US disclosed
US-4180386-A ANTIKNOCK FUEL ADDITIVES E. I. DU PONT DE NEMOURS & COMPANY (US) 1979-12-25 US disclosed